Renal manifestations in children with neurofibromatosis type 1

dc.contributor.authorCelik, Binnaz
dc.contributor.authorAksoy, Ozlem Yuksel
dc.contributor.authorBastug, Funda
dc.contributor.authorPoyrazoglu, Hatice Gamze
dc.date.accessioned2026-08-12T18:06:53Z
dc.date.issued2021
dc.departmentFırat Üniversitesi
dc.description.abstractNeurofibromatosis type 1 (NF1) is an autosomal-dominant neurocutaneous syndrome affecting various parts of the body, including the renovascular and urinary systems. We evaluated the renovascular, urinary, glomerular, and tubular functions of children with NFL We compared blood pressures, urinary findings, and renal glomerular and tubular functions in children with NF1 with those of a healthy age- and gender-matched control group. We evaluated 46 NF1 patients and 33 healthy controls. The mean ages of the NF1 group (female/male: 20/26) and the control group (female/male: 15/18) were 10.1 +/- 4.6 and 10.6 +/- 4.3 years respectively. Six NF1 patients were hypertensive. The mean blood pressures of the NF1 group were significantly higher than those of the control group. Renal artery stenosis was detected in one NF1 patient. Urinary tract anomalies were evident in 21.7% of NF1 but only 9% of control subjects. The mean estimated glomerular filtration rate (eGFR) of the NF1 group was significantly lower than that of the control group. Six NF1 patients evidenced eGFRs < 90 mL/min. In the NF1 group, tubular phosphorus reabsorption was significantly lower and uric acid excretion significantly higher than in the control group. Conclusion: Hypertension, urinary tract anomalies, and impaired renal function were more common in NF1 patients than healthy controls. Regular blood pressure measurements and evaluation of urinary tract and kidney function are essential for NF1 patients.
dc.identifier.doi10.1007/s00431-021-04144-6
dc.identifier.endpage3482
dc.identifier.issn0340-6199
dc.identifier.issn1432-1076
dc.identifier.issue12
dc.identifier.orcid0000-0001-8852-0067
dc.identifier.orcid0000-0001-7905-3524
dc.identifier.orcid0000-0002-6733-4836
dc.identifier.pmid34091747
dc.identifier.scopus2-s2.0-85107472150
dc.identifier.scopusqualityQ1
dc.identifier.startpage3477
dc.identifier.urihttps://doi.org/10.1007/s00431-021-04144-6
dc.identifier.urihttps://hdl.handle.net/11508/62485
dc.identifier.volume180
dc.identifier.wosWOS:000658244800001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofEuropean Journal of Pediatrics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectChildren
dc.subjecteGFR
dc.subjectNeurofibromatosis type 1
dc.subjectRenal manifestations
dc.titleRenal manifestations in children with neurofibromatosis type 1
dc.typeArticle

Dosyalar